Literature DB >> 27587544

Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis.

Giovanni Sotgiu1,2, Simon Tiberi3,2, Lia D'Ambrosio4,5,2, Rosella Centis4,2, Jan Willem Alffenaar6,2, Jose A Caminero7,8,2, Marcos Abdo Arbex9,10, Valentina Alarcon Guizado11, Alena Aleksa12, Simone Dore13, Mina Gaga14, Gina Gualano15, Heinke Kunst16, Marie-Christine Payen17, Aurora Jazmín Roby Arias18, Alena Skrahina19, Ivan Solovic20, Giorgia Sulis21, Marina Tadolini22, Alimuddin Zumla23,2, Giovanni Battista Migliori4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27587544     DOI： 10.1183/13993003.01249-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  17 in total

1.  The shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible?

Authors:  Cynthia B E Chee; Kyi-Win KhinMar; Li-H Sng; Roland Jureen; Jeffery Cutter; Vernon J M Lee; Yee-Tang Wang
Journal:  Eur Respir J       Date:  2017-08-10       Impact factor: 16.671

2.  Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.

Authors:  John Z Metcalfe; Elizabeth Streicher; Grant Theron; Rebecca E Colman; Christopher Allender; Darrin Lemmer; Rob Warren; David M Engelthaler
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

3.  Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives.

Authors:  Adrian Rendon; Simon Tiberi; Anna Scardigli; Lia D'Ambrosio; Rosella Centis; Jose A Caminero; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

4.  Performance of a lateral flow immunochromatography test for the rapid diagnosis of active tuberculosis in a large multicentre study in areas with different clinical settings and tuberculosis exposure levels.

Authors:  Selene Manga; Rocio Perales; Maria Reaño; Lia D'Ambrosio; Giovanni Battista Migliori; Massimo Amicosante
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

5.  Eligibility for a Shorter Treatment Regimen for Multidrug-resistant Tuberculosis in the United States, 2011-2016.

Authors:  Clarisse A Tsang; Neha Shah; Lori R Armstrong; Suzanne M Marks
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

Review 6.  Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.

Authors:  Lia D'Ambrosio; Rosella Centis; Simon Tiberi; Marina Tadolini; Margareth Dalcolmo; Adrian Rendon; Susanna Esposito; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

7.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

Review 8.  New Drugs for the Treatment of Tuberculosis.

Authors:  Elisa H Ignatius; Kelly E Dooley
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 4.967

Review 9.  Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?

Authors:  Marcela Muñoz-Torrico; Adrian Rendon; Rosella Centis; Lia D'Ambrosio; Zhenia Fuentes; Carlos Torres-Duque; Fernanda Mello; Margareth Dalcolmo; Rogelio Pérez-Padilla; Antonio Spanevello; Giovanni Battista Migliori
Journal:  J Bras Pneumol       Date:  2016 Sep-Oct       Impact factor: 2.624

Review 10.  Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review.

Authors:  Giovanni Battista Migliori; Emanuele Pontali; Giovanni Sotgiu; Rosella Centis; Lia D'Ambrosio; Simon Tiberi; Marina Tadolini; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2017-02-07       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.